Categories: MenopauseNews

Mira Introduces Ultra4™, the First At-Home Hormone Monitor with Lab-Quality 4-in-1 Testing

SAN FRANCISCO, Aug. 25, 2025 /PRNewswire/ — Mira, a leading hormonal health company, launches Ultra4, the first at-home hormone monitor to deliver lab-quality insights into four key hormones (FSH, LH, E3G, and PdG) with just one wand and a 16-minute test. For the first time, people can see their full cycle story — from ovulation strength to hormonal balance — with the same precision once only available in clinics.

The new kit measures FSH, LH, E3G, and PdG together — offering a complete hormonal profile across the cycle. This helps users identify imbalances, track shifts over time, and better understand fertility, perimenopause, and overall cycle health. Ultra4 is the only tracker on the market powered by fluorescent technology – the same used in clinical laboratories – and offers up to seven times the accuracy of other fertility trackers on the market. With Mira’s AI-powered app, users can test any day of their cycle, or multiple times daily, for personalized insights.

New features include:

  • 4D Ovulation Profiling – Assesses not just ovulation timing, but its strength and viability
  • Egg Prep Scan – Shows follicle development early in the cycle
  • Hormonal Fingerprint – Builds a personal baseline to flag imbalances
  • Cycle Balance Analysis – Evaluates hormone ratios for overall harmony
  • Egg Count Intelligence – Tracks FSH for at-home insights into ovarian reserve

“When we launched Mira, it was with one hormone and one goal: help women understand fertility,” said Sylvia Kang, CEO and Co-founder. “Ultra4 is our answer to deeper questions about cycles, egg quality, and hormonal health.”

Ultra4 represents Mira’s effort to address a persistent blind spot in women’s health: the lack of accessible, continuous hormone data. Mira’s mission extends beyond fertility to creating a comprehensive hormone health platform that tracks key markers like cortisol, testosterone. The company is developing wearable tech to bring real-time, multi-hormone monitoring into everyday life, transforming hormone data into vital signs for personalized health.

About Mira
Mira is a San Francisco-based hormonal health company providing integrative care and hormonal testing Mira was founded in late 2015 with a mission to develop data-driven hormonal health solutions to help women make confident health decisions during every stage of their lives – from the menstrual stage to menopause.

For more information on Mira, please visit miracare.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/mira-introduces-ultra4-the-first-at-home-hormone-monitor-with-lab-quality-4-in-1-testing-302537856.html

SOURCE Quanovate Tech Inc, dba Mira

Staff

Recent Posts

The UA Sprinkler Fitters Local 669 JATC – Notice of Privacy Incident

Landover, Maryland, February 6, 2026- The UA Sprinkler Fitters Local 669 Joint Apprenticeship and Training…

3 hours ago

Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro

Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin…

9 hours ago

GEARWRENCH Continues to Redefine Automotive Diagnostics with Powerful New Tools

Four new products available now to put full diagnostics in the palm of technician's handsSPARKS,…

9 hours ago

Tampa General’s Innovation Week Returns with New Programming to Showcase Breakthroughs in Patient Care and Technology

Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and…

9 hours ago

New England Biolabs ® Proudly Partners with Automation Providers to Support NGS Library Prep Automation Globally

IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several…

9 hours ago

Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…

15 hours ago